Stay updated on FRα Clinical Trial: Mirvetuximab vs. Chemo
Sign up to get notified when there's something new on the FRα Clinical Trial: Mirvetuximab vs. Chemo page.

Latest updates to the FRα Clinical Trial: Mirvetuximab vs. Chemo page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Fallopian tube cancer and Primary Peritoneal carcinoma to the study conditions, expanding the list of eligible diseases. The page revision is updated to v3.4.2 and the older funding notice has been removed.SummaryDifference0.2%

- Check21 days agoChange DetectedThe page now displays a government funding status notice and updates the revision to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check28 days agoChange DetectedNew UI elements are introduced: a 'Show glossary' option, and additional metadata fields 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' appear on the page. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and the earlier revision 'v3.3.4' are removed.SummaryDifference0.1%

- Check42 days agoChange Detected- Revision metadata updated: added Revision: v3.3.4 and removed Revision: v3.3.3.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations section replaced with a comprehensive new list of study sites across the US, Canada, and Europe. Old per-state location groupings were removed, and the page revision was updated to v3.3.3.SummaryDifference2%

- Check92 days agoChange DetectedThe Publications section text now states that publications are automatically filled from PubMed, and the revision labels show v3.3.2 (replacing v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to FRα Clinical Trial: Mirvetuximab vs. Chemo
Enter your email address, and we'll notify you when there's something new on the FRα Clinical Trial: Mirvetuximab vs. Chemo page.